Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
The Journal of Clinical Investigation|May 1, 2019
SMAD signaling promotes melanoma metastasis independently of phenotype switchingEylul Tuncer, Raquel R Calçada, Daniel Zingg, et al.International Angiology : a Journal of the International Union of Angiology|November 14, 2023
Enhancing identification and treatment of patients with concomitant chronic venous insufficiency and diabetes mellitus. A modified Delphi study from the CODAC (ChrOnic venous disease and Diabetes Advisory Council) groupAhmet K Bozkurt, Marie J VAN Rijn, Eliete Bouskela, et al.Science Translational Medicine|December 2, 2016
Improved cancer immunotherapy by a CD25-mimobody conferring selectivity to human interleukin-2Natalia Arenas-Ramirez, Chao Zou, Simone Popp, et al.Nature Cell Biology|July 10, 2012
Sox10 promotes the formation and maintenance of giant congenital naevi and melanomaOlga Shakhova, Daniel Zingg, Simon M Schaefer, et al.Genome Biology|April 18, 2015
Methylation-dependent SOX9 expression mediates invasion in human melanoma cells and is a negative prognostic factor in advanced melanomaPhil F Cheng, Olga Shakhova, Daniel S Widmer, et al.Oncoimmunology|March 3, 2020
Response of metastatic mouse invasive lobular carcinoma to mTOR inhibition is partly mediated by the adaptive immune systemSjoerd Klarenbeek, Chris W Doornebal, Sjors M Kas, et al.Cancer Cell|July 17, 2018
EZH2-Mediated Primary Cilium Deconstruction Drives Metastatic Melanoma FormationDaniel Zingg, Julien Debbache, Rodrigo Peña-Hernández, et al.Cell Stem Cell|April 6, 2019
Yin Yang 1 Orchestrates a Metabolic Program Required for Both Neural Crest Development and Melanoma FormationSandra Varum, Arianna Baggiolini, Luis Zurkirchen, et al.Nature Communications|January 23, 2015
The epigenetic modifier EZH2 controls melanoma growth and metastasis through silencing of distinct tumour suppressorsDaniel Zingg, Julien Debbache, Simon M Schaefer, et al.Plos Genetics|January 29, 2015
Antagonistic cross-regulation between Sox9 and Sox10 controls an anti-tumorigenic program in melanomaOlga Shakhova, Phil Cheng, Pravin J Mishra, et al.Pageof 3